---
$id: https://graph.org.ai/products/commodity/51111854
$type: Product
source: UNSPSC
code: "51111854"
title: "Nafarelin"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nafarelin

**UNSPSC Code**: 51111854
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a gonadotropin-releasing hormone analog with the molecular formula C66H83N17O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1X0094V6JV, chemically known as luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-d-alanine)- but generally known as nafarelin, which bears US NIH Compound Identifier 16129618. European Medicines Agency schedules Nafarelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09115MIG. The term NAFARELIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules nafarelin in its Anatomical Therapeutic Chemical (ATC) Classification. NAFARELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nafarelin under HS 29371900 and SITC 54154. As of Q4 2014, NAFARELIN remains the US FDA Preferred Term for this commodity. Nafarelin bears US NLM identifiers UMLS ID C0064906 and NCI Concept Code C61613. SMILES: O=C(N1C(CCC1)C(=O)NCC(=O)N)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C1NC(=O)CC1)CC1NC[NH]C1)CC1C2C([NH]C1)CCCC2)CO)CC1CCC(O)CC1)CC1CC2C(CC1)CCCC2)CC(C)C)CCCNC(=N)N.

